United States · FDA National Drug Code directory
Phexxi
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69751-100_11e3cfeb-3ae2-4e97-88f9-3e4cdf770659
- Product NDC
- 69751-100
- Form
- GEL
- Composition / generic term
- lactic acid, L-, citric acid monohydrate, and potassium bitartrate
- Labeler
- Evofem, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200801
- Source listing expiry
- 20261231
Source-listed ingredients
- LACTIC ACID, L- — 90 mg/5g
- CITRIC ACID MONOHYDRATE — 50 mg/5g
- POTASSIUM BITARTRATE — 20 mg/5g
These values do not establish equivalence or a dose recommendation.
Packages
- 3 APPLICATOR in 1 BOX (69751-100-03) / 5 g in 1 APPLICATOR (69751-100-01) · 69751-100-03
- 12 APPLICATOR in 1 BOX (69751-100-12) / 5 g in 1 APPLICATOR (69751-100-01) · 69751-100-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →